bioAffinity Technologies

Biotechnology, Biotechnology, Biotechnology: in vitro & in vivo diagnostic substances, Health care, Health, wellness & fitness

Founded in 2014

San Antonio, Texas

http://www.bioaffinitytech.com

None

About bioAffinity Technologies

Addressing a critical need to find cancer early and treat cancer specifically, bioAffinity Technologies, Inc. develops tests and therapies to detect and treat cancer at the cellular level. Our first product, CyPath® Flow Cytometry for Lung Cancer (CyPath® Lung), has been licensed by Precision Pathology Services for continued development and commercial sale as a Laboratory Developed Test. CyPath® Lung has the potential to dramatically increase overall diagnostic accuracy leading to increased survival, fewer unnecessary invasive procedures and lower patient anxiety and medical costs.

Company Metrics

Employees: 11-50
Monthly Visits: None
Tech Stack: None active products

Financial Information

Estimated Revenue: Less than $1M
Total Funding: 18.3M None
Last Funding: 9.2M None (None)
Funding Status: None

Technology Stack

bioAffinity Technologies actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Biotechnology, Biotechnology: in vitro & in vivo diagnostic substances, Health care, Health, wellness & fitness

Headquarters: San Antonio, Texas

Leadership